News

BioLineRx Announces FDA Approval of Aphexda for Multiple Myeloma Treatment

1 Mins read

BioLineRx, a leading biopharmaceutical company, has received FDA approval for the use of Aphexda motixafortide in combination with filgrastim to mobilize stem cells for the treatment of patients with multiple myeloma.

What is Aphexda?

Aphexda is a groundbreaking medication that effectively mobilizes hematopoietic stem cells from the peripheral blood. These stem cells can then be collected and used for autologous transplantation, which has shown great promise in the treatment of multiple myeloma.

The Importance of Stem Cell Mobilization

Successful autologous stem cell transplantation requires adequate mobilization of stem cells during the treatment process. Aphexda has demonstrated its ability to effectively mobilize these vital cells, improving the outcomes for patients with multiple myeloma.

FDA Approval Based on Promising Results

The FDA’s approval of Aphexda was based on the compelling results of a comprehensive Phase 3 trial. This trial evaluated the safety and efficacy of Aphexda in combination with filgrastim, compared to a placebo with filgrastim.

Multiple Myeloma: A Persistent Challenge

Multiple myeloma is an aggressive and currently incurable blood cancer that primarily affects certain white blood cells. It is the second most common hematologic malignancy, posing significant challenges to healthcare providers and patients alike.

With the FDA approval of Aphexda, BioLineRx is set to make this innovative treatment available to patients later this month.

Related posts
News

7 Token Presales to Watch in 2025: Blazpay ($BLAZ) Takes the Lead

4 Mins read
The world of token presales has always attracted attention, but 2025 is shaping up to be a pivotal year. With a crowded…
News

Naira rallies to N1,455/$; reserves hit $43bn

5 Mins read
The positive rally of the local currency against the dollar continued yesterday with the naira exchanging at N1,455 to one dollar even…
News

Trump Quietly Grants Defense Guarantee To Autocracy That Gave Him A Luxury Jet

4 Mins read
WASHINGTON – Just months after soliciting and receiving a $400 million luxury airliner for himself from Qatar, President Donald Trump has now…

Leave a Reply

Your email address will not be published. Required fields are marked *

17 − = 8